L-Asparaginase-based treatment of 15 western patients with extranodal NK/ T-cell lymphoma and leukemia and a review of the literature

Annals of Oncology

Volumn 20, Issue 1, 2009, Pages 110-116

  Jaccard, Arnaud ^a   Petit, B ^a   Girault, S ^a   Suarez, F ^b   Gressin, R ^c   Zini, J M ^d   Coiteux, V ^e   Larroche, C ^f   Devidas, A ^g   Thieblemont C ^h   Gaulard, P ⁱ   Marin, B ^a   Gachard, N ^a   Bordessoule, D ^a   Hermine, O ^b  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d HÔPITAL LARIBOISIÈRE   (France)

^e Centre Hospitalier Universitaire   (France)

^f AVICENNE HOSPITAL   (France)

^g Department of Pathology   (France)

^h SAINT LOUIS HOSPITAL   (France)

ⁱ HENRI MONDOR HOSPITAL   (France)

Author keywords

L asparaginase; NK T cell lymphoma

Indexed keywords

ASPARAGINASE; ASPARAGINASE MACROGOL; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; VINCRISTINE;

ADULT; AGED; ANAPHYLAXIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD TOXICITY; CANCER REGRESSION; CANCER RELAPSE; CANCER STAGING; CLINICAL ARTICLE; DIABETES MELLITUS; DISSEMINATED CANCER; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG TREATMENT FAILURE; EXTRANODAL NATURAL KILLER T CELL LYMPHOMA; FEMALE; HEMATOLOGIC MALIGNANCY; HEPATITIS; HUMAN; LIVER TOXICITY; MALE; MULTIPLE CYCLE TREATMENT; NATURAL KILLER CELL LEUKEMIA; NEUTROPENIA; PANCREATITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; THROMBOEMBOLISM;

EID: 58949104000     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn542     Document Type: Article

References (26)

1. Emile JF, Boulland ML, Haioun C et al. CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 1996; 87: 1466-1473.
2. Kluin PM, Feller A, Gaulard P et al. Peripheral T/NK-cell lymphoma: A report of the IXth Workshop of the European Association for Haematopathology. Histopathology 2001; 38: 250-270.
3. Jaffe ES, Lee Harris N, Stein H, Vardiman JW. Tumors of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumors: IARC Press 2001.
4. Oshimi K. Progress in understanding and managing natural killer-cell malignancies. Br J Haematol 2007; 139(4): 532-544.
5. Ryder J, Wang X, Bao L et al. Aggressive natural killer cell leukemia: report of a Chinese series and review of the literature. Int J Hematol 2007; 85: 18-25.
6. Isobe K, Uno T, Tamaru J et al. Extranodal natural killer/T-cell lymphoma, nasal type: The significance of radiotherapeutic parameters. Cancer 2006; 106: 609-615.
7. Chim CS, Ma SY, Au WY et al. Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood 2004; 103: 216-221.
8. Matsumoto Y, Nomura K, Kanda-Akano Y et al. Successful treatment with Erwinia L-asparaginase for recurrent natural killer/T cell lymphoma. Leuk Lymphoma 2003; 44: 879-882.
9. Cheson BD, Pfistner B, Juweid ME et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007; 25: 579-586.
10. Yamaguchi M, Oguchi M, Tobinai K et al. Phase I/II study of concurrent chemoradiotherapy for newly-diagnosed, localized nasal NK/T-cell lymphoma: Results of a phase I portion of JC0G0211-DI. Blood 2005; 106: (Abstr 2685).
11. Lee KW, Yun T, Kim DW et al. First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma. Leuk Lymphoma 2006; 47: 1274-1282.
12. Kwong YL. Natural killer-cell malignancies: Diagnosis and treatment. Leukemia 2005; 19: 2186-2194.
13. Tang QL, Liu WP, Li GD et al. Clinicopathologic features and prognostic factors of nasal and nasal-type NK/T lymphoma in South-West China. Tumor 2003; 23: 411-413.
14. Yamaguchi M, Kita K, Miwa H et al. Frequent expression of P-glycoprotein/ MDR1 by nasal T-cell lymphoma cells. Cancer 1995; 76: 2351-2356.
15. Charamella LJ, Meyer C, Thompson GE, Dimitrov NV. Chemotherapeutic agents and modulation of natural killer cell activity in vitro. J Immunopharmacol 1985; 7: 53-65.
16. Ando M, Sugimoto K, Kitoh T et al. Selective apoptosis of natural killer-cell tumours by L-asparaginase. Br J Haematol 2005; 130: 860-868.
17. Yong W, Zheng W, Zhang Y. Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma. Zhonghua Yi Xue Za Zhi 2001; 81: 773-775.
18. Yong W, Zheng W, Zhang Y et al. L-asparaginase-based regimen in the treatment of refractory midline nasal/nasal-type T/NK-cell lymphoma. Int J Hematol 2003; 78: 163-167.
19. Yong W, Zheng W, Zhu J et al. Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors. Hematol Oncol 2006; 24: 28-32.
20. Yamaguchi M, Suzuki R, Kwong YL et al. Phase I study of dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia. Cancer Sci 2008; 99: 1016-1020.
21. Nagafuji K, Fujisaki T, Arima F, Ohshima K. L-asparaginase induced durable remission of relapsed nasal NK/T-cell lymphoma after autologous peripheral blood stem cell transplantation. Int J Hematol 2001; 74: 447-450.
22. Obama K, Tara M, Niina K. L-asparaginase-based induction therapy for advanced extranodal NK/T-cell lymphoma. Int J Hematol 2003; 78: 248-250.
23. Hyakuna N, Toguchi S, Higa T et al. Childhood blastic NK cell leukemia successfully treated with L-asparagenase and allogeneic bone marrow transplantation. Pediatr Blood Cancer 2004; 42: 631-634.
24. Sakamoto E, Yamane T, Nakane T et al. Temporary effective treatment with L-asparaginase for a patient with refractory nasal NK/T-cell lymphoma. Gan To Kagaku Ryoho 2005; 32: 1993-1996. [in Japanese].
25. Yokoyama H, Yamada MF, Ishizawa K et al. Successful treatment of advanced extranodal NK/T cell lymphoma with unrelated cord blood transplantation. Tohoku J Exp Med 2007; 211: 395-399.
26. Berk V, Yildiz R, Akdemir UO et al. Disseminated extranodal NK/T-cell lymphoma, nasal type, with multiple subcutaneous nodules: Utility of 18F-FDG PET in staging. Clin Nucl Med 2008; 33: 365-366.